nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—PTGS2—head and neck cancer	0.74	1	CbGaD
Mefenamic acid—AKR1C3—Vincristine—Vinblastine—head and neck cancer	0.00678	1	CbGdCrCtD
Mefenamic acid—Gastrointestinal perforation—Docetaxel—head and neck cancer	0.00399	0.0258	CcSEcCtD
Mefenamic acid—Enterocolitis—Docetaxel—head and neck cancer	0.00375	0.0243	CcSEcCtD
Mefenamic acid—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.00341	0.0221	CcSEcCtD
Mefenamic acid—Peptic ulcer—Vinblastine—head and neck cancer	0.00329	0.0213	CcSEcCtD
Mefenamic acid—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00297	0.0192	CcSEcCtD
Mefenamic acid—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.00245	0.0159	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—TP53—head and neck cancer	0.00244	0.221	CrCbGaD
Mefenamic acid—Rectal haemorrhage—Vinblastine—head and neck cancer	0.00243	0.0157	CcSEcCtD
Mefenamic acid—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00212	0.0137	CcSEcCtD
Mefenamic acid—Ulcer—Hydroxyurea—head and neck cancer	0.00212	0.0137	CcSEcCtD
Mefenamic acid—Heartburn—Fluorouracil—head and neck cancer	0.0021	0.0136	CcSEcCtD
Mefenamic acid—Deafness—Vinblastine—head and neck cancer	0.00178	0.0115	CcSEcCtD
Mefenamic acid—Eye irritation—Fluorouracil—head and neck cancer	0.00169	0.0109	CcSEcCtD
Mefenamic acid—Hepatic failure—Hydroxyurea—head and neck cancer	0.00162	0.0105	CcSEcCtD
Mefenamic acid—Ulcer—Fluorouracil—head and neck cancer	0.00153	0.00987	CcSEcCtD
Mefenamic acid—Heartburn—Docetaxel—head and neck cancer	0.00151	0.00979	CcSEcCtD
Mefenamic acid—Oesophagitis—Fluorouracil—head and neck cancer	0.00132	0.00853	CcSEcCtD
Mefenamic acid—Coma—Fluorouracil—head and neck cancer	0.00132	0.00853	CcSEcCtD
Mefenamic acid—Pancytopenia—Vinblastine—head and neck cancer	0.00131	0.00847	CcSEcCtD
Mefenamic acid—Sepsis—Fluorouracil—head and neck cancer	0.00125	0.0081	CcSEcCtD
Mefenamic acid—Floctafenine—PTGS2—head and neck cancer	0.00125	0.114	CrCbGaD
Mefenamic acid—Pancreatitis—Hydroxyurea—head and neck cancer	0.00123	0.00798	CcSEcCtD
Mefenamic acid—Eye irritation—Docetaxel—head and neck cancer	0.00122	0.00789	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00121	0.00784	CcSEcCtD
Mefenamic acid—Myocardial infarction—Vinblastine—head and neck cancer	0.00121	0.0078	CcSEcCtD
Mefenamic acid—Pancytopenia—Hydroxyurea—head and neck cancer	0.00119	0.00773	CcSEcCtD
Mefenamic acid—Photosensitivity—Fluorouracil—head and neck cancer	0.00119	0.00772	CcSEcCtD
Mefenamic acid—Dysuria—Hydroxyurea—head and neck cancer	0.00118	0.00761	CcSEcCtD
Mefenamic acid—Agranulocytosis—Vinblastine—head and neck cancer	0.00115	0.00742	CcSEcCtD
Mefenamic acid—Oliguria—Docetaxel—head and neck cancer	0.00113	0.00731	CcSEcCtD
Mefenamic acid—Drowsiness—Hydroxyurea—head and neck cancer	0.00112	0.00725	CcSEcCtD
Mefenamic acid—Haemoglobin—Vinblastine—head and neck cancer	0.00111	0.00718	CcSEcCtD
Mefenamic acid—Haemorrhage—Vinblastine—head and neck cancer	0.0011	0.00714	CcSEcCtD
Mefenamic acid—Hearing impaired—Docetaxel—head and neck cancer	0.00109	0.00708	CcSEcCtD
Mefenamic acid—Stomatitis—Hydroxyurea—head and neck cancer	0.00109	0.00707	CcSEcCtD
Mefenamic acid—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00105	0.00678	CcSEcCtD
Mefenamic acid—Haemoglobin—Hydroxyurea—head and neck cancer	0.00101	0.00655	CcSEcCtD
Mefenamic acid—Haemorrhage—Hydroxyurea—head and neck cancer	0.00101	0.00651	CcSEcCtD
Mefenamic acid—Hallucination—Hydroxyurea—head and neck cancer	0.001	0.00648	CcSEcCtD
Mefenamic acid—Colitis—Docetaxel—head and neck cancer	0.001	0.00647	CcSEcCtD
Mefenamic acid—Fluid retention—Docetaxel—head and neck cancer	0.000988	0.0064	CcSEcCtD
Mefenamic acid—Alopecia—Vinblastine—head and neck cancer	0.000975	0.00631	CcSEcCtD
Mefenamic acid—Oesophagitis—Docetaxel—head and neck cancer	0.000951	0.00616	CcSEcCtD
Mefenamic acid—Sepsis—Docetaxel—head and neck cancer	0.000904	0.00585	CcSEcCtD
Mefenamic acid—Eosinophilia—Fluorouracil—head and neck cancer	0.000896	0.0058	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Vinblastine—head and neck cancer	0.000891	0.00577	CcSEcCtD
Mefenamic acid—Alopecia—Hydroxyurea—head and neck cancer	0.000889	0.00575	CcSEcCtD
Mefenamic acid—Anaemia—Vinblastine—head and neck cancer	0.000888	0.00575	CcSEcCtD
Mefenamic acid—Malaise—Vinblastine—head and neck cancer	0.000866	0.00561	CcSEcCtD
Mefenamic acid—Vertigo—Vinblastine—head and neck cancer	0.000863	0.00559	CcSEcCtD
Mefenamic acid—Leukopenia—Vinblastine—head and neck cancer	0.00086	0.00556	CcSEcCtD
Mefenamic acid—Pancytopenia—Fluorouracil—head and neck cancer	0.00086	0.00556	CcSEcCtD
Mefenamic acid—Deafness—Docetaxel—head and neck cancer	0.000845	0.00547	CcSEcCtD
Mefenamic acid—Hepatic failure—Docetaxel—head and neck cancer	0.000841	0.00544	CcSEcCtD
Mefenamic acid—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000833	0.00539	CcSEcCtD
Mefenamic acid—Convulsion—Vinblastine—head and neck cancer	0.000832	0.00539	CcSEcCtD
Mefenamic acid—Hypertension—Vinblastine—head and neck cancer	0.000829	0.00537	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000826	0.00535	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000813	0.00526	CcSEcCtD
Mefenamic acid—Pneumonia—Fluorouracil—head and neck cancer	0.000812	0.00525	CcSEcCtD
Mefenamic acid—Anaemia—Hydroxyurea—head and neck cancer	0.00081	0.00524	CcSEcCtD
Mefenamic acid—Discomfort—Vinblastine—head and neck cancer	0.000808	0.00523	CcSEcCtD
Mefenamic acid—Lumiracoxib—PTGS2—head and neck cancer	0.000807	0.0733	CrCbGaD
Mefenamic acid—Tiaprofenic acid—PTGS2—head and neck cancer	0.000807	0.0733	CrCbGaD
Mefenamic acid—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000795	0.00515	CcSEcCtD
Mefenamic acid—Renal impairment—Docetaxel—head and neck cancer	0.000794	0.00514	CcSEcCtD
Mefenamic acid—Myocardial infarction—Fluorouracil—head and neck cancer	0.000791	0.00512	CcSEcCtD
Mefenamic acid—Malaise—Hydroxyurea—head and neck cancer	0.00079	0.00511	CcSEcCtD
Mefenamic acid—Stomatitis—Fluorouracil—head and neck cancer	0.000787	0.00509	CcSEcCtD
Mefenamic acid—Conjunctivitis—Fluorouracil—head and neck cancer	0.000784	0.00508	CcSEcCtD
Mefenamic acid—Leukopenia—Hydroxyurea—head and neck cancer	0.000784	0.00507	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Vinblastine—head and neck cancer	0.000768	0.00497	CcSEcCtD
Mefenamic acid—Nepafenac—PTGS2—head and neck cancer	0.000767	0.0697	CrCbGaD
Mefenamic acid—Convulsion—Hydroxyurea—head and neck cancer	0.000759	0.00491	CcSEcCtD
Mefenamic acid—Hyponatraemia—Docetaxel—head and neck cancer	0.000759	0.00491	CcSEcCtD
Mefenamic acid—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000756	0.00489	CcSEcCtD
Mefenamic acid—Agranulocytosis—Fluorouracil—head and neck cancer	0.000753	0.00487	CcSEcCtD
Mefenamic acid—Anorexia—Vinblastine—head and neck cancer	0.000747	0.00484	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000741	0.00479	CcSEcCtD
Mefenamic acid—Discomfort—Hydroxyurea—head and neck cancer	0.000737	0.00477	CcSEcCtD
Mefenamic acid—Haemoglobin—Fluorouracil—head and neck cancer	0.000728	0.00471	CcSEcCtD
Mefenamic acid—Haemorrhage—Fluorouracil—head and neck cancer	0.000724	0.00469	CcSEcCtD
Mefenamic acid—Niflumic Acid—PTGS2—head and neck cancer	0.000719	0.0653	CrCbGaD
Mefenamic acid—Oedema—Hydroxyurea—head and neck cancer	0.000715	0.00463	CcSEcCtD
Mefenamic acid—Infection—Hydroxyurea—head and neck cancer	0.00071	0.0046	CcSEcCtD
Mefenamic acid—Paraesthesia—Vinblastine—head and neck cancer	0.000704	0.00456	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0007	0.00453	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Docetaxel—head and neck cancer	0.000698	0.00452	CcSEcCtD
Mefenamic acid—Skin disorder—Hydroxyurea—head and neck cancer	0.000695	0.00449	CcSEcCtD
Mefenamic acid—Anorexia—Hydroxyurea—head and neck cancer	0.000682	0.00441	CcSEcCtD
Mefenamic acid—Decreased appetite—Vinblastine—head and neck cancer	0.000682	0.00441	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000681	0.0044	CcSEcCtD
Mefenamic acid—Constipation—Vinblastine—head and neck cancer	0.00067	0.00434	CcSEcCtD
Mefenamic acid—Arrhythmia—Fluorouracil—head and neck cancer	0.000647	0.00419	CcSEcCtD
Mefenamic acid—Feeling abnormal—Vinblastine—head and neck cancer	0.000646	0.00418	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000641	0.00415	CcSEcCtD
Mefenamic acid—Alopecia—Fluorouracil—head and neck cancer	0.00064	0.00414	CcSEcCtD
Mefenamic acid—Salsalate—PTGS2—head and neck cancer	0.000638	0.0579	CrCbGaD
Mefenamic acid—Dyspnoea—Hydroxyurea—head and neck cancer	0.000637	0.00412	CcSEcCtD
Mefenamic acid—Somnolence—Hydroxyurea—head and neck cancer	0.000636	0.00411	CcSEcCtD
Mefenamic acid—Dyspepsia—Hydroxyurea—head and neck cancer	0.000629	0.00407	CcSEcCtD
Mefenamic acid—Meclofenamic acid—PTGS2—head and neck cancer	0.000628	0.0571	CrCbGaD
Mefenamic acid—Decreased appetite—Hydroxyurea—head and neck cancer	0.000622	0.00402	CcSEcCtD
Mefenamic acid—Pancytopenia—Docetaxel—head and neck cancer	0.00062	0.00401	CcSEcCtD
Mefenamic acid—Abdominal pain—Vinblastine—head and neck cancer	0.00062	0.00401	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000617	0.00399	CcSEcCtD
Mefenamic acid—Constipation—Hydroxyurea—head and neck cancer	0.000611	0.00396	CcSEcCtD
Mefenamic acid—Vision blurred—Fluorouracil—head and neck cancer	0.000594	0.00385	CcSEcCtD
Mefenamic acid—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000589	0.00381	CcSEcCtD
Mefenamic acid—Pneumonia—Docetaxel—head and neck cancer	0.000586	0.00379	CcSEcCtD
Mefenamic acid—Anaemia—Fluorouracil—head and neck cancer	0.000583	0.00377	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000577	0.00374	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000574	0.00372	CcSEcCtD
Mefenamic acid—Renal failure—Docetaxel—head and neck cancer	0.000573	0.0037	CcSEcCtD
Mefenamic acid—Myocardial infarction—Docetaxel—head and neck cancer	0.000571	0.00369	CcSEcCtD
Mefenamic acid—Jaundice—Docetaxel—head and neck cancer	0.000568	0.00367	CcSEcCtD
Mefenamic acid—Stomatitis—Docetaxel—head and neck cancer	0.000568	0.00367	CcSEcCtD
Mefenamic acid—Conjunctivitis—Docetaxel—head and neck cancer	0.000566	0.00366	CcSEcCtD
Mefenamic acid—Body temperature increased—Hydroxyurea—head and neck cancer	0.000565	0.00366	CcSEcCtD
Mefenamic acid—Leukopenia—Fluorouracil—head and neck cancer	0.000564	0.00365	CcSEcCtD
Mefenamic acid—Asthenia—Vinblastine—head and neck cancer	0.000563	0.00364	CcSEcCtD
Mefenamic acid—Diclofenac—CYP1A1—head and neck cancer	0.000562	0.051	CrCbGaD
Mefenamic acid—Convulsion—Fluorouracil—head and neck cancer	0.000546	0.00354	CcSEcCtD
Mefenamic acid—Agranulocytosis—Docetaxel—head and neck cancer	0.000544	0.00352	CcSEcCtD
Mefenamic acid—Diarrhoea—Vinblastine—head and neck cancer	0.000536	0.00347	CcSEcCtD
Mefenamic acid—Discomfort—Fluorouracil—head and neck cancer	0.00053	0.00343	CcSEcCtD
Mefenamic acid—Fenoprofen—PTGS2—head and neck cancer	0.000527	0.0479	CrCbGaD
Mefenamic acid—Haemoglobin—Docetaxel—head and neck cancer	0.000526	0.0034	CcSEcCtD
Mefenamic acid—Haemorrhage—Docetaxel—head and neck cancer	0.000523	0.00338	CcSEcCtD
Mefenamic acid—Hepatitis—Docetaxel—head and neck cancer	0.000523	0.00338	CcSEcCtD
Mefenamic acid—Confusional state—Fluorouracil—head and neck cancer	0.000519	0.00336	CcSEcCtD
Mefenamic acid—Dizziness—Vinblastine—head and neck cancer	0.000518	0.00335	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Docetaxel—head and neck cancer	0.000516	0.00334	CcSEcCtD
Mefenamic acid—Oedema—Fluorouracil—head and neck cancer	0.000515	0.00333	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000515	0.00333	CcSEcCtD
Mefenamic acid—Asthenia—Hydroxyurea—head and neck cancer	0.000513	0.00332	CcSEcCtD
Mefenamic acid—Urethral disorder—Docetaxel—head and neck cancer	0.000513	0.00332	CcSEcCtD
Mefenamic acid—Infection—Fluorouracil—head and neck cancer	0.000511	0.00331	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000504	0.00326	CcSEcCtD
Mefenamic acid—Tachycardia—Fluorouracil—head and neck cancer	0.000502	0.00325	CcSEcCtD
Mefenamic acid—Vomiting—Vinblastine—head and neck cancer	0.000499	0.00323	CcSEcCtD
Mefenamic acid—Erythema multiforme—Docetaxel—head and neck cancer	0.000494	0.0032	CcSEcCtD
Mefenamic acid—Headache—Vinblastine—head and neck cancer	0.000491	0.00318	CcSEcCtD
Mefenamic acid—Anorexia—Fluorouracil—head and neck cancer	0.000491	0.00317	CcSEcCtD
Mefenamic acid—Diarrhoea—Hydroxyurea—head and neck cancer	0.000489	0.00317	CcSEcCtD
Mefenamic acid—Hypotension—Fluorouracil—head and neck cancer	0.000481	0.00311	CcSEcCtD
Mefenamic acid—Acetylsalicylic acid—PTGS2—head and neck cancer	0.000476	0.0433	CrCbGaD
Mefenamic acid—Dizziness—Hydroxyurea—head and neck cancer	0.000473	0.00306	CcSEcCtD
Mefenamic acid—Arrhythmia—Docetaxel—head and neck cancer	0.000467	0.00302	CcSEcCtD
Mefenamic acid—Nausea—Vinblastine—head and neck cancer	0.000466	0.00301	CcSEcCtD
Mefenamic acid—Insomnia—Fluorouracil—head and neck cancer	0.000465	0.00301	CcSEcCtD
Mefenamic acid—Paraesthesia—Fluorouracil—head and neck cancer	0.000462	0.00299	CcSEcCtD
Mefenamic acid—Alopecia—Docetaxel—head and neck cancer	0.000462	0.00299	CcSEcCtD
Mefenamic acid—Dyspnoea—Fluorouracil—head and neck cancer	0.000459	0.00297	CcSEcCtD
Mefenamic acid—Mental disorder—Docetaxel—head and neck cancer	0.000458	0.00296	CcSEcCtD
Mefenamic acid—Somnolence—Fluorouracil—head and neck cancer	0.000458	0.00296	CcSEcCtD
Mefenamic acid—Vomiting—Hydroxyurea—head and neck cancer	0.000455	0.00294	CcSEcCtD
Mefenamic acid—Dyspepsia—Fluorouracil—head and neck cancer	0.000453	0.00293	CcSEcCtD
Mefenamic acid—Rash—Hydroxyurea—head and neck cancer	0.000451	0.00292	CcSEcCtD
Mefenamic acid—Dermatitis—Hydroxyurea—head and neck cancer	0.00045	0.00291	CcSEcCtD
Mefenamic acid—Headache—Hydroxyurea—head and neck cancer	0.000448	0.0029	CcSEcCtD
Mefenamic acid—Decreased appetite—Fluorouracil—head and neck cancer	0.000447	0.0029	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000444	0.00288	CcSEcCtD
Mefenamic acid—PTGS2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000439	0.00502	CbGpPWpGaD
Mefenamic acid—Nausea—Hydroxyurea—head and neck cancer	0.000425	0.00275	CcSEcCtD
Mefenamic acid—Feeling abnormal—Fluorouracil—head and neck cancer	0.000424	0.00274	CcSEcCtD
Mefenamic acid—PTGS2—S1P1 pathway—MAPK3—head and neck cancer	0.000421	0.00482	CbGpPWpGaD
Mefenamic acid—Anaemia—Docetaxel—head and neck cancer	0.000421	0.00272	CcSEcCtD
Mefenamic acid—AKR1C3—Metabolism—UROD—head and neck cancer	0.000416	0.00475	CbGpPWpGaD
Mefenamic acid—Urticaria—Fluorouracil—head and neck cancer	0.000409	0.00265	CcSEcCtD
Mefenamic acid—Syncope—Docetaxel—head and neck cancer	0.000408	0.00264	CcSEcCtD
Mefenamic acid—Leukopenia—Docetaxel—head and neck cancer	0.000407	0.00264	CcSEcCtD
Mefenamic acid—Body temperature increased—Fluorouracil—head and neck cancer	0.000407	0.00263	CcSEcCtD
Mefenamic acid—Palpitations—Docetaxel—head and neck cancer	0.000402	0.0026	CcSEcCtD
Mefenamic acid—PTGS2—S1P1 pathway—MAPK1—head and neck cancer	0.000401	0.00459	CbGpPWpGaD
Mefenamic acid—Loss of consciousness—Docetaxel—head and neck cancer	0.0004	0.00259	CcSEcCtD
Mefenamic acid—Convulsion—Docetaxel—head and neck cancer	0.000394	0.00255	CcSEcCtD
Mefenamic acid—Hypertension—Docetaxel—head and neck cancer	0.000393	0.00254	CcSEcCtD
Mefenamic acid—Salicylic acid—PTGS2—head and neck cancer	0.000392	0.0356	CrCbGaD
Mefenamic acid—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000387	0.00443	CbGpPWpGaD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000385	0.00249	CcSEcCtD
Mefenamic acid—Dry mouth—Docetaxel—head and neck cancer	0.000379	0.00245	CcSEcCtD
Mefenamic acid—Confusional state—Docetaxel—head and neck cancer	0.000375	0.00242	CcSEcCtD
Mefenamic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—head and neck cancer	0.000374	0.00427	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000372	0.00426	CbGpPWpGaD
Mefenamic acid—Oedema—Docetaxel—head and neck cancer	0.000371	0.0024	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Docetaxel—head and neck cancer	0.000371	0.0024	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000371	0.00424	CbGpPWpGaD
Mefenamic acid—Infection—Docetaxel—head and neck cancer	0.000369	0.00239	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000367	0.0042	CbGpPWpGaD
Mefenamic acid—Shock—Docetaxel—head and neck cancer	0.000365	0.00236	CcSEcCtD
Mefenamic acid—Pruritus—Fluorouracil—head and neck cancer	0.000364	0.00236	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Docetaxel—head and neck cancer	0.000364	0.00235	CcSEcCtD
Mefenamic acid—Tachycardia—Docetaxel—head and neck cancer	0.000363	0.00235	CcSEcCtD
Mefenamic acid—Skin disorder—Docetaxel—head and neck cancer	0.000361	0.00233	CcSEcCtD
Mefenamic acid—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00036	0.00412	CbGpPWpGaD
Mefenamic acid—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000357	0.00408	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000355	0.00406	CbGpPWpGaD
Mefenamic acid—Anorexia—Docetaxel—head and neck cancer	0.000354	0.00229	CcSEcCtD
Mefenamic acid—Diarrhoea—Fluorouracil—head and neck cancer	0.000352	0.00228	CcSEcCtD
Mefenamic acid—Diclofenac—PTGS2—head and neck cancer	0.000351	0.0319	CrCbGaD
Mefenamic acid—AKR1C2—Metabolism—NAT2—head and neck cancer	0.000349	0.00399	CbGpPWpGaD
Mefenamic acid—Hypotension—Docetaxel—head and neck cancer	0.000347	0.00225	CcSEcCtD
Mefenamic acid—Flurbiprofen—PTGS2—head and neck cancer	0.000344	0.0312	CrCbGaD
Mefenamic acid—Dizziness—Fluorouracil—head and neck cancer	0.00034	0.0022	CcSEcCtD
Mefenamic acid—Insomnia—Docetaxel—head and neck cancer	0.000336	0.00217	CcSEcCtD
Mefenamic acid—Paraesthesia—Docetaxel—head and neck cancer	0.000334	0.00216	CcSEcCtD
Mefenamic acid—Dyspnoea—Docetaxel—head and neck cancer	0.000331	0.00214	CcSEcCtD
Mefenamic acid—Somnolence—Docetaxel—head and neck cancer	0.00033	0.00214	CcSEcCtD
Mefenamic acid—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000329	0.00376	CbGpPWpGaD
Mefenamic acid—Vomiting—Fluorouracil—head and neck cancer	0.000327	0.00212	CcSEcCtD
Mefenamic acid—Dyspepsia—Docetaxel—head and neck cancer	0.000327	0.00212	CcSEcCtD
Mefenamic acid—Rash—Fluorouracil—head and neck cancer	0.000325	0.0021	CcSEcCtD
Mefenamic acid—Dermatitis—Fluorouracil—head and neck cancer	0.000324	0.0021	CcSEcCtD
Mefenamic acid—Decreased appetite—Docetaxel—head and neck cancer	0.000323	0.00209	CcSEcCtD
Mefenamic acid—Headache—Fluorouracil—head and neck cancer	0.000322	0.00209	CcSEcCtD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000322	0.00369	CbGpPWpGaD
Mefenamic acid—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000321	0.00208	CcSEcCtD
Mefenamic acid—Constipation—Docetaxel—head and neck cancer	0.000318	0.00206	CcSEcCtD
Mefenamic acid—Ketoprofen—PTGS2—head and neck cancer	0.000311	0.0282	CrCbGaD
Mefenamic acid—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000308	0.00353	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—DPYD—head and neck cancer	0.000306	0.0035	CbGpPWpGaD
Mefenamic acid—Feeling abnormal—Docetaxel—head and neck cancer	0.000306	0.00198	CcSEcCtD
Mefenamic acid—Nausea—Fluorouracil—head and neck cancer	0.000306	0.00198	CcSEcCtD
Mefenamic acid—PTGS2—C-MYB transcription factor network—GSTM1—head and neck cancer	0.000305	0.00349	CbGpPWpGaD
Mefenamic acid—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000304	0.00348	CbGpPWpGaD
Mefenamic acid—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000304	0.00197	CcSEcCtD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000295	0.00338	CbGpPWpGaD
Mefenamic acid—Body temperature increased—Docetaxel—head and neck cancer	0.000294	0.0019	CcSEcCtD
Mefenamic acid—Abdominal pain—Docetaxel—head and neck cancer	0.000294	0.0019	CcSEcCtD
Mefenamic acid—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000293	0.00335	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000293	0.00335	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—YAP1—head and neck cancer	0.000291	0.00332	CbGpPWpGaD
Mefenamic acid—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00029	0.00332	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000284	0.00324	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000282	0.00322	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.00028	0.0032	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000272	0.00311	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00027	0.00308	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000267	0.00305	CbGpPWpGaD
Mefenamic acid—Asthenia—Docetaxel—head and neck cancer	0.000267	0.00172	CcSEcCtD
Mefenamic acid—Pruritus—Docetaxel—head and neck cancer	0.000263	0.0017	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism—NAT2—head and neck cancer	0.000256	0.00293	CbGpPWpGaD
Mefenamic acid—Diarrhoea—Docetaxel—head and neck cancer	0.000254	0.00164	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—KISS1—head and neck cancer	0.000252	0.00288	CbGpPWpGaD
Mefenamic acid—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000251	0.00287	CbGpPWpGaD
Mefenamic acid—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00025	0.00286	CbGpPWpGaD
Mefenamic acid—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000248	0.00283	CbGpPWpGaD
Mefenamic acid—Dizziness—Docetaxel—head and neck cancer	0.000246	0.00159	CcSEcCtD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—head and neck cancer	0.000242	0.00276	CbGpPWpGaD
Mefenamic acid—Vomiting—Docetaxel—head and neck cancer	0.000236	0.00153	CcSEcCtD
Mefenamic acid—Rash—Docetaxel—head and neck cancer	0.000234	0.00152	CcSEcCtD
Mefenamic acid—Dermatitis—Docetaxel—head and neck cancer	0.000234	0.00151	CcSEcCtD
Mefenamic acid—Headache—Docetaxel—head and neck cancer	0.000233	0.00151	CcSEcCtD
Mefenamic acid—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000231	0.00264	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000228	0.0026	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—DPYD—head and neck cancer	0.000225	0.00257	CbGpPWpGaD
Mefenamic acid—Nausea—Docetaxel—head and neck cancer	0.000221	0.00143	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.00022	0.00251	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000218	0.0025	CbGpPWpGaD
Mefenamic acid—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.000217	0.00248	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—YAP1—head and neck cancer	0.000213	0.00244	CbGpPWpGaD
Mefenamic acid—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000212	0.00243	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000209	0.00239	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—GRP—head and neck cancer	0.000208	0.00237	CbGpPWpGaD
Mefenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.000206	0.00236	CbGpPWpGaD
Mefenamic acid—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	0.000206	0.00235	CbGpPWpGaD
Mefenamic acid—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000203	0.00233	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—STAT6—head and neck cancer	0.000202	0.00231	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000198	0.00226	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000198	0.00226	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.00019	0.00218	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000183	0.0021	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000181	0.00207	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—BCL2—head and neck cancer	0.000181	0.00207	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—UROD—head and neck cancer	0.000181	0.00207	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—YAP1—head and neck cancer	0.000178	0.00204	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—TYMS—head and neck cancer	0.000175	0.002	CbGpPWpGaD
Mefenamic acid—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000173	0.00198	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—GSTM1—head and neck cancer	0.000173	0.00197	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—NAT2—head and neck cancer	0.000173	0.00197	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—KISS1—head and neck cancer	0.00017	0.00194	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—GPX1—head and neck cancer	0.000165	0.00189	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—CYP1A1—head and neck cancer	0.000164	0.00187	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.00016	0.00183	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00016	0.00183	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000159	0.00181	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—CCND1—head and neck cancer	0.000156	0.00178	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—DPYD—head and neck cancer	0.000151	0.00173	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—UROD—head and neck cancer	0.000144	0.00164	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—YAP1—head and neck cancer	0.000144	0.00164	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00014	0.0016	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.00014	0.0016	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.00014	0.0016	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—GRP—head and neck cancer	0.00014	0.0016	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000138	0.00158	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—STAT6—head and neck cancer	0.000136	0.00155	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000134	0.00154	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000133	0.00152	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000131	0.0015	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—TYMS—head and neck cancer	0.000128	0.00147	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—GSTM1—head and neck cancer	0.000127	0.00145	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL2—head and neck cancer	0.000122	0.00139	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—GPX1—head and neck cancer	0.000121	0.00139	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—CYP1A1—head and neck cancer	0.00012	0.00137	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—YAP1—head and neck cancer	0.00012	0.00137	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—CCND1—head and neck cancer	0.000119	0.00136	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—UROD—head and neck cancer	0.000117	0.00134	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—NOTCH1—head and neck cancer	0.000115	0.00131	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000114	0.0013	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000112	0.00129	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000111	0.00127	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.00011	0.00125	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000108	0.00124	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000108	0.00123	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000107	0.00122	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.86e-05	0.00113	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—HRAS—head and neck cancer	9.8e-05	0.00112	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MAPK3—head and neck cancer	9.78e-05	0.00112	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PTGS2—head and neck cancer	9.73e-05	0.00111	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—UROD—head and neck cancer	9.51e-05	0.00109	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.41e-05	0.00108	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	9.4e-05	0.00107	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MAPK1—head and neck cancer	9.3e-05	0.00106	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—EGFR—head and neck cancer	9.3e-05	0.00106	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	9.06e-05	0.00104	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—TYMS—head and neck cancer	8.62e-05	0.000986	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PTGS2—head and neck cancer	8.52e-05	0.000975	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GSTM1—head and neck cancer	8.52e-05	0.000974	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PTEN—head and neck cancer	8.48e-05	0.00097	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GPX1—head and neck cancer	8.16e-05	0.000933	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CYP1A1—head and neck cancer	8.08e-05	0.000924	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	8.07e-05	0.000922	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NOTCH1—head and neck cancer	8.04e-05	0.000919	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.98e-05	0.000912	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.9e-05	0.000903	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TP53—head and neck cancer	7.81e-05	0.000893	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	7.78e-05	0.00089	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOTCH1—head and neck cancer	7.73e-05	0.000883	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NAT2—head and neck cancer	7.51e-05	0.000859	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PTEN—head and neck cancer	7.43e-05	0.00085	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.38e-05	0.000844	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTGS2—head and neck cancer	7.14e-05	0.000816	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	7.03e-05	0.000804	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	6.65e-05	0.000761	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—STAT3—head and neck cancer	6.65e-05	0.00076	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.64e-05	0.000759	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—DPYD—head and neck cancer	6.59e-05	0.000753	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MAPK3—head and neck cancer	6.35e-05	0.000726	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.33e-05	0.000724	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	6.33e-05	0.000724	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	6.33e-05	0.000724	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.27e-05	0.000717	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—YAP1—head and neck cancer	6.25e-05	0.000715	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTEN—head and neck cancer	6.23e-05	0.000712	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MAPK1—head and neck cancer	6.04e-05	0.000691	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—EGFR—head and neck cancer	6.04e-05	0.000691	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PIK3CA—head and neck cancer	5.98e-05	0.000684	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NAT2—head and neck cancer	5.96e-05	0.000682	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTGS2—head and neck cancer	5.74e-05	0.000656	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL2—head and neck cancer	5.53e-05	0.000633	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	5.49e-05	0.000628	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOTCH1—head and neck cancer	5.41e-05	0.000619	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CCND1—head and neck cancer	5.39e-05	0.000617	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	5.31e-05	0.000608	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PIK3CA—head and neck cancer	5.24e-05	0.0006	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—DPYD—head and neck cancer	5.23e-05	0.000598	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PTEN—head and neck cancer	5.21e-05	0.000595	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.15e-05	0.000589	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.1e-05	0.000583	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTEN—head and neck cancer	5e-05	0.000572	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—YAP1—head and neck cancer	4.96e-05	0.000567	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—AKT1—head and neck cancer	4.89e-05	0.000559	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—HRAS—head and neck cancer	4.85e-05	0.000555	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NAT2—head and neck cancer	4.85e-05	0.000555	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTGS2—head and neck cancer	4.8e-05	0.000549	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—head and neck cancer	4.7e-05	0.000538	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.7e-05	0.000537	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—STAT3—head and neck cancer	4.66e-05	0.000532	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.49e-05	0.000513	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—STAT3—head and neck cancer	4.47e-05	0.000512	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK3—head and neck cancer	4.45e-05	0.000509	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PIK3CA—head and neck cancer	4.39e-05	0.000502	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—AKT1—head and neck cancer	4.28e-05	0.00049	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MAPK3—head and neck cancer	4.27e-05	0.000489	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—DPYD—head and neck cancer	4.25e-05	0.000486	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK1—head and neck cancer	4.23e-05	0.000484	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EGFR—head and neck cancer	4.23e-05	0.000484	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.19e-05	0.000479	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTEN—head and neck cancer	4.19e-05	0.000479	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.15e-05	0.000475	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.09e-05	0.000468	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MAPK1—head and neck cancer	4.07e-05	0.000465	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—EGFR—head and neck cancer	4.07e-05	0.000465	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—YAP1—head and neck cancer	4.04e-05	0.000462	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NAT2—head and neck cancer	3.95e-05	0.000451	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—TYMS—head and neck cancer	3.75e-05	0.000429	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL2—head and neck cancer	3.72e-05	0.000426	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTM1—head and neck cancer	3.71e-05	0.000424	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—PIK3CA—head and neck cancer	3.67e-05	0.00042	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCND1—head and neck cancer	3.63e-05	0.000415	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—AKT1—head and neck cancer	3.59e-05	0.00041	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—head and neck cancer	3.55e-05	0.000406	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GPX1—head and neck cancer	3.55e-05	0.000406	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PIK3CA—head and neck cancer	3.53e-05	0.000404	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP1A1—head and neck cancer	3.52e-05	0.000402	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PTEN—head and neck cancer	3.5e-05	0.000401	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—DPYD—head and neck cancer	3.46e-05	0.000396	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—HRAS—head and neck cancer	3.4e-05	0.000389	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—YAP1—head and neck cancer	3.29e-05	0.000376	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HRAS—head and neck cancer	3.27e-05	0.000373	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.25e-05	0.000372	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—head and neck cancer	3.16e-05	0.000362	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—STAT3—head and neck cancer	3.13e-05	0.000358	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.03e-05	0.000347	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—AKT1—head and neck cancer	3e-05	0.000343	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK3—head and neck cancer	2.99e-05	0.000342	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TYMS—head and neck cancer	2.98e-05	0.000341	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PIK3CA—head and neck cancer	2.96e-05	0.000338	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTM1—head and neck cancer	2.94e-05	0.000337	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.89e-05	0.00033	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—AKT1—head and neck cancer	2.88e-05	0.00033	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK1—head and neck cancer	2.85e-05	0.000326	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EGFR—head and neck cancer	2.85e-05	0.000326	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GPX1—head and neck cancer	2.82e-05	0.000322	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP1A1—head and neck cancer	2.79e-05	0.000319	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOTCH1—head and neck cancer	2.67e-05	0.000305	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.65e-05	0.000302	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CA—head and neck cancer	2.47e-05	0.000283	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.47e-05	0.000282	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TYMS—head and neck cancer	2.42e-05	0.000277	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—AKT1—head and neck cancer	2.41e-05	0.000276	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTM1—head and neck cancer	2.4e-05	0.000274	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—head and neck cancer	2.39e-05	0.000273	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GPX1—head and neck cancer	2.29e-05	0.000262	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.29e-05	0.000262	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HRAS—head and neck cancer	2.29e-05	0.000261	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP1A1—head and neck cancer	2.27e-05	0.00026	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.15e-05	0.000246	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—head and neck cancer	2.09e-05	0.000239	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AKT1—head and neck cancer	2.02e-05	0.000231	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TYMS—head and neck cancer	1.97e-05	0.000226	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.95e-05	0.000223	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GPX1—head and neck cancer	1.87e-05	0.000214	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.87e-05	0.000213	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.85e-05	0.000211	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTEN—head and neck cancer	1.82e-05	0.000209	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PTEN—head and neck cancer	1.73e-05	0.000198	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—STAT3—head and neck cancer	1.55e-05	0.000177	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.52e-05	0.000174	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MAPK3—head and neck cancer	1.48e-05	0.000169	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PTEN—head and neck cancer	1.45e-05	0.000166	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MAPK1—head and neck cancer	1.41e-05	0.000161	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—EGFR—head and neck cancer	1.41e-05	0.000161	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.35e-05	0.000154	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CA—head and neck cancer	1.29e-05	0.000147	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PIK3CA—head and neck cancer	1.22e-05	0.000139	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTEN—head and neck cancer	1.18e-05	0.000135	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HRAS—head and neck cancer	1.13e-05	0.000129	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.1e-05	0.000126	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AKT1—head and neck cancer	1.05e-05	0.00012	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CA—head and neck cancer	1.02e-05	0.000117	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKT1—head and neck cancer	9.96e-06	0.000114	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTEN—head and neck cancer	9.59e-06	0.00011	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AKT1—head and neck cancer	8.34e-06	9.54e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CA—head and neck cancer	8.31e-06	9.5e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AKT1—head and neck cancer	6.79e-06	7.76e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CA—head and neck cancer	6.76e-06	7.73e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AKT1—head and neck cancer	5.53e-06	6.32e-05	CbGpPWpGaD
